Find a Trial Find Expert Physicians 
News Trial Stats
Clinical TrialsFacts & Fears Who pays for it, placebos, being a guinea pig, and what taking part really means.Basics ofTheranostics A fundamental way of finding and treating your cancer, all in one.Basics ofRadiation What is radiation, and how can it benefit you? InterpretingYour Scans What CT, MRI and PET can and can’t tell you about cancer.What to Expect as aTheranostic Patient Scans, treatment day, and the precautions once you are home.Basics ofDosimetry How much radiation each organ and tumor actually absorbs.TheranosticDictionary Plain-language meanings for the vocabulary on your paperwork.
News Trial StatsDark mode
Contact XCancer®
Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT05995236
Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
Overview
This study is a single-center registry study collecting clinical data regarding the treatment of PSMA-positive metastatic castration-resistant prostate cancer treated with PSMA radionuclide therapy per the treating physician's discretion. Clinical data from candidates for or who undergo the PSMA procedure at Methodist Dallas Medical Center from August 2022 to August 2027 will be collected after discharge and patients will undergo clinical follow-up per the treating physician's discretion.
Sponsor
Methodist Health System
Contacts
Alexandru Bageac, MD (PRINCIPAL_INVESTIGATOR)
ClinicalTrials.gov
NCT05995236Eligibility
Inclusion
- Hemoglobin: \>8 g/dL
- Platelet (Thrombocyte) count: \>75 x 109/L
- No prior therapy with Radium-223 Dichloride
- Clear disease progression on PSMA-PET/CT
- PSMA-PET/CT scan positive disease within 6 weeks
- Metastatic or Locally Advanced AND Inoperable
- White blood cell count: \>2K cells/µL
- 2\. Diagnosed with PSMA-positive metastatic castration-resistant prostate cancer and - has consented to undergo PSMA nuclear therapy per the treating physician. Specifically:
- Labs:
Exclusion
- Patients who do not meet the Inclusion Criteria laid out in section 4.2 will be excluded from the study.
Share your feedback
Help us improve your experience